Ultrasound-Guided Supraclavicular Block With vs Without PNS
Launched by AGA KHAN UNIVERSITY · Jul 22, 2025
Trial Information
Current as of August 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a type of anesthesia called a supraclavicular block, which helps numb the arm for surgery. The study compares two ways of guiding this nerve block: one uses ultrasound imaging alone to see the nerves, and the other uses ultrasound plus a technique called peripheral nerve stimulation (PNS), which helps confirm the nerve’s exact location by causing small muscle movements. The goal is to find out if using both methods together makes the nerve block safer and more successful than using ultrasound alone.
Adults aged 18 and older who are having surgery on the middle to lower arm, elbow, forearm, wrist, or hand may be eligible to join, as long as they are generally healthy enough for regional anesthesia and can communicate clearly about their symptoms. People with nerve problems, bleeding issues, or cognitive difficulties won’t be able to participate. If you join, the team will perform the nerve block using one of the two methods and closely monitor how well it works and how safe it is. This study hasn’t started recruiting yet, but it aims to improve pain control during arm surgeries by finding the best way to guide nerve blocks.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 years and older
- • ASA physical status I to IV
- • No contraindications to regional anaesthesia
- • Operative site located at the mid to lower arm, including the elbow, forearm, wrist, or hand
- • Ability to provide informed consent
- • Ability to reliably report symptoms to the research team related to regional anaesthesia
- Exclusion Criteria:
- • Patient's refusal to participate.
- • Inability to provide first-party consent due to cognitive impairment.
- • Cognitive dysfunction which can lead to difficulties in communication and cooperation of patient.
- • Preexisting neuropathy.
- • Preexisting coagulopathy.
- • Patients who will be shifted to ICU due to post - operative ventilatory support.
About Aga Khan University
Aga Khan University (AKU) is a distinguished institution dedicated to improving health and education across developing regions. Established in 1983, AKU is recognized for its commitment to research excellence, particularly in clinical trials that address pressing health issues in diverse populations. With a focus on advancing medical knowledge and practice, AKU's clinical trial initiatives are designed to foster innovative solutions and enhance patient care. The university collaborates with various local and international partners, leveraging its multidisciplinary expertise to conduct rigorous research that informs public health policy and improves health outcomes in communities served by its facilities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, Sindh, Pakistan
Patients applied
Trial Officials
Azhar Rehman, Mbbs Fcps
Principal Investigator
Aga Khan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported